ID: ALA4750436

Max Phase: Preclinical

Molecular Formula: C13H8F3NO3S2

Molecular Weight: 347.34

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1sccc1C(=O)O)c1ccc(SC(F)(F)F)cc1

Standard InChI:  InChI=1S/C13H8F3NO3S2/c14-13(15,16)22-8-3-1-7(2-4-8)10(18)17-11-9(12(19)20)5-6-21-11/h1-6H,(H,17,18)(H,19,20)

Standard InChI Key:  ODVPIYHGTQNLPE-UHFFFAOYSA-N

Associated Targets(Human)

Potassium channel subfamily K member 10 76 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Potassium channel subfamily K member 2 490 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 347.34Molecular Weight (Monoisotopic): 346.9898AlogP: 4.31#Rotatable Bonds: 4
Polar Surface Area: 66.40Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.76CX Basic pKa: CX LogP: 5.29CX LogD: 2.01
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.81Np Likeness Score: -1.83

References

1. Iwaki Y,Yashiro K,Kokubo M,Mori T,Wieting JM,McGowan KM,Bridges TM,Engers DW,Denton JS,Kurata H,Lindsley CW.  (2019)  Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249.,  29  (13.0): [PMID:31072652] [10.1016/j.bmcl.2019.04.048]

Source